Todos Med Stock Price, News & Analysis
TOMDF
OTC Link
Company Description
Todos Medical Ltd. engineers innovative diagnostic solutions for early cancer detection using the Todos Biochemical Infrared Analyses (TBIA), focusing on cancer's impact on the immune system through blood analysis. The company has developed TMB-1 and TMB-2 cancer screening tests and acquired Provista Diagnostics, Inc. for PCR COVID testing and the Videssa® breast cancer blood test.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Todos Med.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Todos Med (TOMDF)?
The current stock price of Todos Med (TOMDF) is $0.000001 as of September 19, 2025.
What is the market cap of Todos Med (TOMDF)?
The market cap of Todos Med (TOMDF) is approximately 21.3K. Learn more about what market capitalization means .
What technology does Todos Medical Ltd. use for cancer detection?
Todos Medical Ltd. uses the Todos Biochemical Infrared Analyses (TBIA), a proprietary technology that examines cancer's effect on the immune system through blood analysis.
What are TMB-1 and TMB-2 cancer screening tests?
TMB-1 and TMB-2 are cancer screening tests developed by Todos Medical Ltd. that have received a CE mark in Europe.
What did Todos Medical Ltd. acquire Provista Diagnostics, Inc. for?
Todos Medical Ltd. acquired Provista Diagnostics, Inc. for access to its PCR COVID testing and the proprietary Videssa® breast cancer blood test.
What is the focus of Todos Medical Ltd. on Long COVID?
Todos Medical Ltd. aims to address the Long COVID epidemic by deploying medical foods, immune support supplements, and precision diagnostic panels for Long COVID patients.
What is the recent corporate update from Todos Medical Ltd.?
Todos Medical Ltd. provided a corporate update centered on focusing on Long COVID, with a new agreement with NLC Pharma for licensing Tollovid, Tollovir, and TolloTest products.
What is the innovative approach of Todos Medical Ltd. for cancer detection?
Todos Medical Ltd. introduces a novel approach for cancer detection based on cancer's influence on the immune system, triggering biochemical changes.
What is the significance of the appointment of a trustee related to an insolvency order by Todos Medical Ltd.?
Todos Medical Ltd. announced the appointment of a trustee in response to an insolvency order and liquidation request filed by the Company's Founder and former Director, President & CEO.